10-9
Dr Reddy’s says US FDA issued Form 483 with two observations for its FTO-11 facility in Andhra Pradesh
India’s Dr Reddy’s Laboratories said the US Food and Drug Administration completed a pre-approval inspection at its FTO-11 manufacturing facility in Andhra Pradesh and issued a Form 483 with two observations. The company said it will respond and address the observations within the stipulated timeline. The stock closed down 1.86% in the prior session, and the company’s market capitalisation was about Rs 98,487 crore.
10-9
10-8
India’s grain buffer tops norms on July 1, 2026, offering a cushion as global food risks rise
India’s wheat inventories as of July 1 were up about 46% from a year earlier, with rice stocks also ample. The 2025-26 wheat output forecast was raised to 1.207 billion tonnes, nearly 10% higher than the previous year. Government procurement also strengthened, with 2026-27 purchases reaching about 33.80 million tonnes by June 15, above the year-ago pace. The government plans to release reserves via open-market sales to steady domestic food prices and curb inflation.
10-8